MilliporeSigma
  • Home
  • Search Results
  • Collagen VI Deficiency Results in Structural Abnormalities in the Mouse Lung.

Collagen VI Deficiency Results in Structural Abnormalities in the Mouse Lung.

The American journal of pathology (2019-12-16)
Jared A Mereness, Soumyaroop Bhattacharya, Yue Ren, Qian Wang, Christopher S Anderson, Kathy Donlon, Andrew M Dylag, Jeannie Haak, Alessia Angelin, Paolo Bonaldo, Thomas J Mariani
ABSTRACT

Collagen VI (COL6) is known for its role in a spectrum of congenital muscular dystrophies, which are often accompanied by respiratory dysfunction. However, little is known regarding the function of COL6 in the lung. We confirmed the presence of COL6 throughout the basement membrane region of mouse lung tissue. Lung structure and organization were studied in a previously described Col6a1-/- mouse, which does not produce detectable COL6 in the lung. The Col6a1-/- mouse displayed histopathologic alveolar and airway abnormalities. The airspaces of Col6a1-/- lungs appeared simplified, with larger (29%; P < 0.01) and fewer (31%; P < 0.001) alveoli. These airspace abnormalities included reduced isolectin B4+ alveolar capillaries and surfactant protein C-positive alveolar epithelial type-II cells. Alterations in lung function consistent with these histopathologic changes were evident. Col6a1-/- mice also displayed multiple airway changes, including increased branching (59%; P < 0.001), increased mucosal thickness (34%; P < 0.001), and increased epithelial cell density (13%; P < 0.001). Comprehensive transcriptome analysis revealed that the loss of COL6 is associated with reductions in integrin-paxillin-phosphatidylinositol 3-kinase signaling in vivo. In vitro, COL6 promoted steady-state phosphorylated paxillin levels and reduced cell density (16% to 28%; P < 0.05) at confluence. Inhibition of phosphatidylinositol 3-kinase, or its downstream effectors, resulted in increased cell density to a level similar to that seen on matrices lacking COL6.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Streptomycin Sulfate, Streptomyces sp. - CAS 3810-74-0 - Calbiochem, Streptomycin Sulfate, Streptomyces sp., CAS 3810-74-0, is an antibiotic effective against Gram-positive and Gram-negative bacteria. Blocks initiation, elongation, and termination in prokaryotes.
Sigma-Aldrich
Deoxyribonuclease I from bovine pancreas, lyophilized powder, Protein ≥85 %, ≥400 Kunitz units/mg protein
Supelco
Sodium Citrate, Dihydrate
Sigma-Aldrich
Retinoic acid, ≥98% (HPLC), powder